Lactobacillus Helveticus
Marketed as a "psychobiotic", almost always as the R0052 strain paired with Bifidobacterium longum R0175. The mood findings come from one small early study and have not been convincingly replicated.
Evidence last reviewed: August 2026
What the science says
- Mood and anxiety Limited evidence
The often-cited study combined rat experiments with a small human trial of L. helveticus R0052 plus B. longum R0175 and reported reduced psychological distress scores. It was small, tested a two-strain combination, and later trials of the same combination have given mixed results.
- Gastrointestinal symptoms Limited evidence
A randomized controlled trial of the R0052/R0175 combination in female dancers found some improvement in gastrointestinal symptoms alongside metabolomic changes, in a small and highly specific population.
- Common cold prevention Limited evidence
A randomized, double-blind, placebo-controlled trial reported that L. helveticus reduced the onset of common colds and activated dendritic cells; this is a single trial and needs replication.
Dosage & safety
Scientific references
- Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects
- A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers
- Lactobacillus helveticus Induces Two Types of Dendritic Cell Activation and Effectively Suppresses Onset of the Common Cold: A Randomized, Double-Blind, Placebo-Controlled Trial
Where to buy
Referral link — this site may earn a commission on purchases.
Related in Gut health
- Probiotics Moderate evidence
- Psyllium Husk (fiber) Strong evidence
- L-Glutamine Limited evidence
- Oregano Oil Limited evidence
- Ginger Moderate evidence
- Inulin (Prebiotic Fiber) Moderate evidence